Other studies indicated that the Bcl-2 family proteins were central components of the sorafenib cytotoxicity in hepatoma cells [38], and Bcl-xL level had been connected to HCC growth and sorafenib-resistance [39, 40]. This evidence concerns the gene BCL2 and hepatocellular carcinoma.